Yes — however you need to bear in mind the legal restrictions on the maximum quantity of pseudoephedrine mg and ephedrine mg that can be sold, and the restriction against selling the two medicines together in a single transaction Regulation of Human Medicines Regulations Yes, the sale or supply of pseudoephedrine or ephedrine should either be made personally by the pharmacist or by pharmacy staff who have been trained on pseudoephedrine and ephedrine issues, knowing when to refer to the pharmacist where necessary.
They may be male, female and of any age or background. Contact your local GPhC inspector on or your local controlled drugs liaison police officer. Contact us. Workforce Wellbeing More info. Pharmacist Prescribing More info. The PJ. Pharmacy Guides. Shortly after the ephedrine ban another potentially dangerous stimulant called methylhexaneamine DMAA also popped up in supplements and the FDA stopped companies from selling these products.
Thus they are virtually unregulated unless an issue arises. But when many adverse reactions are reported, a substance may be deemed unsafe and the FDA is to step in and ban its sale.
Second and more importantly, it may be an adulterant that turns out to be too dangerous for the average person to consume. Unlike ephedrine, we have not learned of thousands of adverse events being reported to the FDA.
So despite BMPEA being an amphetamine isomer, use may not be as unsafe as it is being made to look, whether or not the drug belongs in supplements. The FDA has been aware of some dietary supplements containing BMPEA for over two years now, but they have not yet recalled these products or issued a public warning that some products contain this drug.
However, these new findings from the Harvard researchers may in fact prompt a warning. But there is always a chance that a warning will be somewhat ineffective and that, like ephedrine, this drug may remain available. If people were using BMPEA to get high if it is even possible instead of using it for fitness purposes, it would be a different story and the Drug Enforcement Administration DEA would likely step in to control use.
Putting discussion of the need for proper testing and labeling aside, is the appearance of this new drug really unexpected? The FDA recommends that consumers read the labels of OTC drug products to determine if the product contains pseudoephedrine, ephedrine, or phenylpropanolamine.
FDA believes this to be the most accurate method for determining the contents of OTC products rather than providing an incomplete or out-of-date list of products that may have already been reformulated and no longer contain these ingredients. Products containing pseudoephedrine are already considered prescription controlled substances in my state. Does this new law change that status? In response to the misuse of methamphetamine, many state governments have issued regulations controlling the sale of these products.
This should not effect the restrictions already placed in your state. I have chronic sinus problems. Will I be limited from getting the amount of pseudoephedrine I need? Yes, with this new law there will be limits on the number of tablets of ephedrine, pseudoephedrine, or phenylpropanolamine that can be purchased in a day period.
As there are many different dosages and formulations of these products, you should ask your pharmacist how much you will be allowed to purchase over a day period for specific product you use.
In other words, placement may be in a secure location in the pharmacy prescription-filling area or in a locked cabinet that is located in the area of the facility to which customers do not have direct access. In all cases, the seller will deliver the product directly into the custody of the buyer.
Will training be required for personnel responsible for selling pseudoephedrine? Companies selling products containing pseudoephedrine are required to submit to the Attorney General a statement regarding self-certification and training on the new law. What about a sample size package containing only pills of pseudoephedrine like those often sold at gas stations or grocery stores?
These single dose packages have to remain behind the counter. What is FDA announcing today? Who has responsibility for enforcement of the Act?
0コメント